Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$5.33 - $8.18 $67,691 - $103,886
-12,700 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.5 - $9.19 $1.07 Million - $1.79 Million
-194,300 Reduced 93.86%
12,700 $92,000
Q4 2021

Feb 14, 2022

BUY
$7.67 - $44.59 $1.59 Million - $9.23 Million
207,000 New
207,000 $1.85 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $283M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.